We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Mini-Sponge Wound Dressing Controls Hemorrhage

By HospiMedica International staff writers
Posted on 20 Dec 2015
A syringe-like device injects a large number of tiny, rapidly expanding sponges into a wound cavity, quickly controlling bleeding when tourniquets are not an option.

The XStat 30 device is a 30 mm diameter applicator shaped like a large syringe that holds 92 tablet-sized, mini-cellulose sponges that are coated with an absorbent hemostatic agent. More...
Once injected into a bleeding wound, the compressed sponges expand when they come in contact with fluids, thus rapidly filling a volume substantially larger than that of their compressed state. Besides helping to provide hemostasis for up to four hours until surgery, the sponges also provide a surface on which blood clots can begin to form.

The Xstat 30 is intended for use in patients at high risk for immediate, life-threatening and severe hemorrhagic shock and for use in non-compressible junctional wounds, such as the armpit or groin, or when definitive care at an emergency care facility cannot be reached within minutes. It is not indicated for use in the thorax, pleural cavity, mediastinum, abdomen, retroperitoneal space, sacral space, or in tissues above the clavicle. Since the sponges are eventually removed, each has a tiny radiopaque marker that is visible on X-ray.

The XStat 30 device, a product of RevMedx (Wilsonville, OR, USA), will be marketed in packages of one or three applicators, each with a telescoping handle and a sealed valve tip; the telescoping mechanism allows the handle to be stored in a shortened state to maximize compactness. The number of sponges necessary to stop bleeding depends on the size and depth of the wound, with each applicator capable of absorbing about 570 mL blood, and with up to three applicators indicated for use on a given patient.

“The majority of people with massive abdominal bleeding die before they reach the hospital,” said David King, MD, a trauma surgeon at Massachusetts General Hospital (Boston, MA, USA). “Many of these deaths could be prevented if we were able to temporarily stabilize a patient long enough to reach a trauma center.”

Related Links:

RevMedx



New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Multi-Chamber Washer-Disinfector
WD 390
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.